Parexel

What an impactful week at the SCOPE Summit, filled with thoughtful conversations, fresh perspectives and meaningful collaboration across the clinical research community. From AI-enabled clinical trial delivery, patient and site engagement to agile operating models and regulatory strategy considerations, the discussions reinforced how much progress is driven by partnership, innovation and shared purpose. Thank you to everyone who joined our sessions and took the time to connect with our team. Click through to see some of our favorite moments from #SCOPE2026 📷 #SCOPESummit

Proud to see this work publicized! A recent National Institute for Health and Care Research (NIHR) case study highlights how Parexel supported two pivotal U.K. vaccine trials—for norovirus and influenza—achieving exemplary timelines. How? ✔️ Smart site selection and activation ✔️ Innovative recruitment strategies ✔️ Clear leadership and governance ✔️ Streamlined costing and contracting ✔️ True cross-sector collaboration This model demonstrates what's achievable with strong collaboration with sponsors, CROs, sites and national health initiatives like the U.K. Vaccine Innovation Pathway. Quality and speed go hand in hand, and patients get medicines faster. 👏 Read how it was done: https://brnw.ch/21wZIV9

We don’t often get to talk publicly about our work because of sponsor confidentiality — so it’s great to see this NIHR article highlighting how two important UK vaccine trials, in norovirus and influenza, were accelerated with support from the Parexel team. Speed + quality in clinical trials isn’t just an operational win — it’s how you shorten the distance between science and patients, especially in areas that place huge pressure on the NHS every winter. For context: norovirus is estimated to cause around 3 million cases in the UK each year and both flu and norovirus contribute to thousands of hospital admissions and significant bed pressures annually. Proud of the teams and the partnerships that made this happen. 👏 More in the comments.

It is not every day that Parexel can discuss details of the work we perform. While CROs are actively involved in bringing lifesaving treatments to patients, our work is not often publicized due to appropriate confidentiality measures. But this article, published with all the necessary approvals, highlights an example of true partnership between sponsor, CRO, national health agencies, and sites, to deliver remarkable outcomes and results. I want to personally highlight and thank Leslie (Thamer) Johnston, Anne Kasmar MD MSc, Carly Correll, Martin Tochacek, Jonathan Shepherd, Dipali N. and all members of the Parexel project teams that contributed to these amazing achievements. #BestCRO #WithHeart

Strong discussion yesterday at #SCOPESummit on what it really takes to keep complex clinical trials moving forward.   Parexel's Kushal Gohil and Karen McIntyre joined a panel presenting a concept centered on real-time feedback across sponsors, sites and CROs — designed to surface issues early, enable faster decision-making and support meaningful course correction while trials are still in motion.   The discussion focused on how continuous, shared insights during a trial can strengthen alignment, improve collaboration and ultimately accelerate better trial and patient outcomes without sacrificing quality or compliance. The session closed with an open invitation to the audience to help shape the next phase of this concept, reinforcing that meaningful progress is built collaboratively.   #SCOPESummit2026 

This February marks a historic milestone: the 100th anniversary of Black History Month in the U.S. Since 1926, this observance has honored the enduring contributions of Black Americans while amplifying overlooked stories of brilliance and resilience and strides for equality. At Parexel, our Black Employees Advisory Consortium (BEACON) embodies this spirit of progress. With 200+ colleagues strong, BEACON is committed to advancing global inclusion for both Black employees and the Black patients we serve With Heart. Over the past year, BEACON has: ▪️Invested in talent with leadership development programs and mentoring opportunities for women and men ▪️Expanded networks by participating in conferences with organizations like the Healthcare Businesswomen's Association and Black Women In Clinical Research ® ▪️Built connections through virtual Lunch & Learns, book clubs, coffee chats and local meet ups ▪️Celebrated excellence as members earned recognition from Black Pharma, PharmaTimes Media Ltd and other organizations As we honor this centennial, we're proud of BEACON's work to create lasting change and we're committed to continuing this important journey together.

The conversations happening across SCOPE are shaping how the clinical trial ecosystem is evolving. From agile outsourcing models and stronger site engagement in decentralized and hybrid trials, to responsible AI adoption and better alignment across sponsors, sites and CROs, these sessions have focused on practical ways to modernize clinical trial delivery. The common thread is clear: Real progress comes from rethinking operating models, strengthening partnerships and designing trials around collaboration, quality and patient impact. If you’re onsite, come visit us at booth #601 and keep these conversations going: https://lnkd.in/e_gFZf2Z #SCOPE2026 #SCOPESummit #SiteEngagement

We're proud to announce that Parexel has once again been recognized in the Human Rights Campaign Foundation's Corporate Equality Index for our commitment to LGBTQ+ equality and inclusion. This recognition — with a five-point increase — reflects the dedication of our Global Inclusion team's leadership, the advocacy of our Parexel Pride business resource group and the commitment of our global colleagues who champion inclusion every day. 🌈 Thank you to everyone who helps make Parexel a place where all employees can thrive. Learn more about the Corporate Equality Index: https://brnw.ch/21wZEB5 #Inclusion #LGBTQ

At today’s session, 𝘈𝘐 𝘢𝘴 𝘵𝘩𝘦 𝘊𝘢𝘵𝘢𝘭𝘺𝘴𝘵: 𝘙𝘦-𝘐𝘮𝘢𝘨𝘪𝘯𝘪𝘯𝘨 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘛𝘳𝘪𝘢𝘭 𝘋𝘦𝘭𝘪𝘷𝘦𝘳𝘺, our Chief Operating Officer, Rob Goodwin, explored how AI can accelerate predictability and speed, but only when paired with purpose-driven processes, integrated data and redefined roles. True transformation doesn’t come from layering technology onto legacy systems. It comes from rethinking how trials are designed, delivered and experienced. Stop by booth #601 and schedule a meeting with our team to continue the conversation: https://lnkd.in/e_gFZf2Z #SCOPE2026 #SCOPESummit #AIinClinicalTrials